Kalvista Pharmaceuticals News and Activities

Presence

KalVista Pharmaceuticals develops medicines for rare diseases. Its main products are oral and injectable treatments for hereditary angioedema and related conditions, serving patients, healthcare providers, and specialty care partners.

Kalvista Pharmaceuticals products and services overview:

Rare disease treatments
Hereditary angioedema drugs
Oral medicines
Injectable therapies
Drug development

Revenue: ~$0 million

Employees: 160

Headquarters: Cambridge, United States (USA)

Kalvista Pharmaceuticals is one of the...

Kalvista Pharmaceuticals is a company listed under the stock ticker KALV (US).

Executives

View the org chart displaying its 26 main executives

Most searched biographies at Kalvista Pharmaceuticals

Popular executive movements at Kalvista Pharmaceuticals

Linea Aspesi has joined the company as Chief People Officer (posted on October 6 2025).
Bilal Arif has joined the company as Chief Operating Officer (posted on October 6 2025).
Bethany Sensenig has joined the company as Director (posted on October 2 2025).

Create your alert
to follow the executive moves at Kalvista Pharmaceuticals.